| 摘要 |
A process for manufacturing of a composition containing a purified factor for supporting wound healing selected from the group consisting of hepatocyte growth factor (HGF), platelet derived growth factor (PDGF), epidermal growth factor (EGF), transforming growth factor alfa (TGF-α), transforming growth factor beta (TGF-&bgr;), insulin like growth factor (IGF-I) and fibroblast growth factor (FGF) from sources, such as blood, containing the factor for supporting wound healing, wherein the manufacturing process comprises purification steps which are performed in the presence of antithrombin III (AT-III). |
